Answers are grounded in this paper and cite their sources.
The association between cumulative intrapartum oxytocin exposure and postpartum haemorrhage (PPH) remains uncertain, particularly for uterine-atony-related PPH and nonlinear dose–response relationships. We conducted a retrospective cohort study of singleton live vaginal births with reliable positive intrapartum oxytocin exposure. Cumulative dose was reconstructed from infusion records. Logistic models compared > 10 with ≤ 10 IU, adjusting for maternal and obstetric characteristics and induction versus augmentation. Additional analyses examined labour duration, forceps-assisted delivery, infusion duration and nonlinear associations. Among 9,893 women, 9,392 received ≤ 10 IU and 501 received > 10 IU; PPH occurred in 4.30% and 9.18%, respectively. In the complete-case model ( n = 9,730), > 10 IU was associated with all-cause PPH (adjusted odds ratio [OR] 1.73, 95% confidence interval [CI] 1.23–2.44) and strict uterine-atony-related PPH (OR 1.94, 95% CI 1.35–2.77). After additional adjustment for the first and second stages combined, the estimates were attenuated to 1.24 (0.86–1.78) and 1.35 (0.93–1.98), respectively. Infusion duration remained associated with both outcomes in these labour-adjusted models, with ORs per hour of 1.033 (1.012–1.054) and 1.036 (1.015–1.059). Dose and duration were highly correlated (Spearman ρ = 0.956). Higher cumulative dose was associated with PPH among oxytocin recipients, but the estimates were sensitive to labour-duration adjustment. Longer infusion duration also showed an association. These observational findings support considering the labour course when interpreting cumulative exposure, but establish neither causality nor a clinical dose ceiling.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: